236 related articles for article (PubMed ID: 26630010)
21. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
[TBL] [Abstract][Full Text] [Related]
22. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis.
Weiss JB; Xue C; Benice T; Xue L; Morris SW; Raber J
Pharmacol Biochem Behav; 2012 Jan; 100(3):566-74. PubMed ID: 22079349
[TBL] [Abstract][Full Text] [Related]
24. A ligand for ALK.
Lemke G; Lew ED
Sci Signal; 2015 Jan; 8(360):fs2. PubMed ID: 25605971
[TBL] [Abstract][Full Text] [Related]
25. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.
Motegi A; Fujimoto J; Kotani M; Sakuraba H; Yamamoto T
J Cell Sci; 2004 Jul; 117(Pt 15):3319-29. PubMed ID: 15226403
[TBL] [Abstract][Full Text] [Related]
26. Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase.
Kuo AH; Stoica GE; Riegel AT; Wellstein A
Oncogene; 2007 Feb; 26(6):859-69. PubMed ID: 16878150
[TBL] [Abstract][Full Text] [Related]
27. Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.
Carpenter EL; Haglund EA; Mace EM; Deng D; Martinez D; Wood AC; Chow AK; Weiser DA; Belcastro LT; Winter C; Bresler SC; Vigny M; Mazot P; Asgharzadeh S; Seeger RC; Zhao H; Guo R; Christensen JG; Orange JS; Pawel BR; Lemmon MA; Mossé YP
Oncogene; 2012 Nov; 31(46):4859-67. PubMed ID: 22266870
[TBL] [Abstract][Full Text] [Related]
28. Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma.
Fukuhara S; Nomoto J; Kim SW; Taniguchi H; Miyagi Maeshima A; Tobinai K; Kobayashi Y
Hematol Oncol; 2018 Feb; 36(1):150-158. PubMed ID: 28665006
[TBL] [Abstract][Full Text] [Related]
29. Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.
Moog-Lutz C; Degoutin J; Gouzi JY; Frobert Y; Brunet-de Carvalho N; Bureau J; Créminon C; Vigny M
J Biol Chem; 2005 Jul; 280(28):26039-48. PubMed ID: 15886198
[TBL] [Abstract][Full Text] [Related]
30. Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo.
Kozutsumi H; Toyoshima H; Hagiwara K; Yazaki Y; Hirai H
Oncogene; 1994 Oct; 9(10):2991-8. PubMed ID: 8084603
[TBL] [Abstract][Full Text] [Related]
31. Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
Takezawa K; Okamoto I; Nishio K; Jänne PA; Nakagawa K
Clin Cancer Res; 2011 Apr; 17(8):2140-8. PubMed ID: 21415216
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).
Ouyang T; Bai RY; Bassermann F; von Klitzing C; Klumpen S; Miething C; Morris SW; Peschel C; Duyster J
J Biol Chem; 2003 Aug; 278(32):30028-36. PubMed ID: 12748172
[TBL] [Abstract][Full Text] [Related]
33. Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma.
Okubo J; Takita J; Chen Y; Oki K; Nishimura R; Kato M; Sanada M; Hiwatari M; Hayashi Y; Igarashi T; Ogawa S
Oncogene; 2012 Nov; 31(44):4667-76. PubMed ID: 22249260
[TBL] [Abstract][Full Text] [Related]
34. LTK and ALK promote neuronal polarity and cortical migration by inhibiting IGF1R activity.
Christova T; Ho SK; Liu Y; Gill M; Attisano L
EMBO Rep; 2023 Jul; 24(7):e56937. PubMed ID: 37291945
[TBL] [Abstract][Full Text] [Related]
35. Dermatan sulphate is an activating ligand of anaplastic lymphoma kinase.
Machino M; Gong Y; Ozaki T; Suzuki Y; Watanabe E; Imagama S; Kadomatsu K; Sakamoto K
J Biochem; 2021 Dec; 170(5):631-637. PubMed ID: 34270745
[TBL] [Abstract][Full Text] [Related]
36. Growth and survival signals transmitted via two distinct NPXY motifs within leukocyte tyrosine kinase, an insulin receptor-related tyrosine kinase.
Ueno H; Sasaki K; Kozutsumi H; Miyagawa K; Mitani K; Yazaki Y; Hirai H
J Biol Chem; 1996 Nov; 271(44):27707-14. PubMed ID: 8910363
[TBL] [Abstract][Full Text] [Related]
37. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.
Stoica GE; Kuo A; Aigner A; Sunitha I; Souttou B; Malerczyk C; Caughey DJ; Wen D; Karavanov A; Riegel AT; Wellstein A
J Biol Chem; 2001 May; 276(20):16772-9. PubMed ID: 11278720
[TBL] [Abstract][Full Text] [Related]
38. The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice.
Mori M; Ueno Y; Konagai S; Fushiki H; Shimada I; Kondoh Y; Saito R; Mori K; Shindou N; Soga T; Sakagami H; Furutani T; Doihara H; Kudoh M; Kuromitsu S
Mol Cancer Ther; 2014 Feb; 13(2):329-40. PubMed ID: 24419060
[TBL] [Abstract][Full Text] [Related]
39. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?
Mathivet T; Mazot P; Vigny M
Cell Signal; 2007 Dec; 19(12):2434-43. PubMed ID: 17904822
[TBL] [Abstract][Full Text] [Related]
40. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.
Debruyne DN; Bhatnagar N; Sharma B; Luther W; Moore NF; Cheung NK; Gray NS; George RE
Oncogene; 2016 Jul; 35(28):3681-91. PubMed ID: 26616860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]